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Abstract – Entamoeba histolytica is an extracellular tissue parasite causing colitis and occasional liver abscess in
humans. E. histolytica-derived secretory products (SPs) contain large amounts of cysteine proteases (CPs), one of
the important amoebic virulence factors. Although tissue-residing mast cells play an important role in the mucosal
inﬂammatory response to this pathogen, it is not known whether the SPs induce mast cell activation. In this study, when
human mast cells (HMC-1 cells) were stimulated with SPs collected from pathogenic wild-type amoebae, interleukin
IL-8 mRNA expression and production were signiﬁcantly increased compared with cells incubated with medium alone.
Inhibition of CP activity in the SPs with heat or the CP inhibitor E64 resulted in signiﬁcant reduction of IL-8 produc-
tion. Moreover, SPs obtained from inhibitors of cysteine protease (ICP)-overexpressing amoebae with low CP activity
showed weaker stimulatory effects on IL-8 production than the wild-type control. Preincubation of HMC-1 cells with
antibodies to human protease-activated receptor 2 (PAR2) did not affect the SP-induced IL-8 production. These results
suggest that cysteine proteases in E. histolytica-derived secretory products stimulate mast cells to produce IL-8 via a
PAR2-independent mechanism, which contributes to IL-8-mediated tissue inﬂammatory responses during the early
phase of human amoebiasis.
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Re´sume´ – Les cyste´ine prote´ases secre´te´es par Entamoeba histolytica induisent la production d’IL-8 chez les
mastocytes humains par un me´canisme inde´pendant de PAR2. Entamoeba histolytica est un parasite
extracellulaire des tissus provoquant des colites et occasionnellement des abce`s du foie chez l’homme. Les produits
de se´cre´tion de´rive´s d’E. histolytica (SPs) contiennent de grandes quantite´s de cyste´ine-prote´ases (CPs), l’un des
principaux facteurs de virulence amibiens. Bien que les mastocytes tissulaires jouent un roˆle important dans la
re´ponse inﬂammatoire de la muqueuse a` ce pathoge`ne, on ne sait pas si les SPs induisent l’activation des
mastocytes. Dans cette e´tude, lorsque des mastocytes humains (cellules HMC-1) ont e´te´ stimule´s avec des SPs
recueillis a` partir d’amibes pathoge`nes de type sauvage, l’expression et la production de l’interleukine IL-8 ont e´te´
signiﬁcativement augmente´es par rapport a` des cellules incube´es avec du milieu seul. L’inhibition de l’activite´ des
CPs dans les SPs avec la chaleur ou avec E64, un inhibiteur de CP, a entraıˆne´ une re´duction signiﬁcative de la
production d’IL-8. En outre, les SPs obtenus a` partir d’amibes surexprimant l’inhibiteur de prote´ases a` cyste´ine
(ICP) a` faible activite´ de CP ont montre´ des effets stimulants plus faibles sur la production d’IL-8 que le controˆle
de type sauvage. La pre´-incubation des cellules HMC-1 avec des anticorps contre le re´cepteur 2 active´ par la
prote´ase humaine (PAR2) n’a pas affecte´ la production d’IL-8 induite par SPs. Ces re´sultats sugge`rent que les
cyste´ine-prote´ases des produits de se´cre´tion de´rive´s d’E. histolytica stimulent les mastocytes pour produire de l’IL-8
par l’interme´diaire d’un me´canisme inde´pendant de PAR2, ce qui contribue a` la re´ponse inﬂammatoire tissulaire
me´die´e par IL-8 au cours de la phase pre´coce de l’amibiase humaine.
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Introduction
The enteric protozoan parasite Entamoeba histolytica
Schaudinn, 1903 [25] is the causative agent of human amoebi-
asis. E. histolytica trophozoites bind colonic mucin via amoebic
Gal-lectin and subsequently cause mucin degradation and colo-
nic epithelial cell death through apoptosis or necrosis [19, 20].
E. histolytica releases various proteases into the extracellular
milieu. In particular, cysteine proteases (CPs) are abundant in
E. histolytica-derived secretory products (SPs). CPs are impor-
tant for host mucin and extracellular matrix (ECM) degrada-
tion [11], cytopathic effects on the host cell, and activation of
IL-1 b or IL-18.
E. histolytica-induced colon cell death promotes IL-8-med-
iated acute tissue inﬂammation at the site of infection [26]. IL-8
is a potent chemoattractant and activator of neutrophils and can
cause non-speciﬁc tissue damage after activation [9]. Although
neutrophils are the primary target cells of IL-8, IL-8 has other
effects on various kinds of cells such as endothelial cells, other
granulocytes, macrophages, and mast cells. The inﬁltration of
immune cells including neutrophils, macrophages, and mast
cells at the mucosal surface was observed during E. histolytica
intestinal amoebiasis, suggesting that these cells might be
important in host defense against this parasite [13]. Moreover,
an increase in degranulation and disruption of mast cells was
reported in E. histolytica–infected mice [16], suggesting that
mast cells play a role in E. histolytica–induced tissue inﬂamma-
tion at the inﬂamed site. However, the precise role of amoebic
CPs in mast cell activation is poorly understood.
Mast cells contribute to the innate and adaptive host defense
mechanisms through the release of an arsenal of inﬂammatory
mediators upon activation by various stimuli [3, 12]. Tissue-
residing mast cells are major players in the mucosal inﬂamma-
tory response to various bacterial and parasitic infections [6].
Activated mast cells release various proinﬂammatory mediators
including histamine, IL-6, IL-8, IL-13, prostaglandin D2, leuko-
triene C4 (LTC4), and tumor necrosis factor-a (TNF-a) in
response to various stimuli [14]. The essential role of mast cells
in the host control of infection has been shown in animal
models infected with various bacterial and parasitic patho-
gens [2, 4, 28]. However, little is known about the effect of
amoebic SPs on IL-8 secretion in mast cells.
In this study, mast cells were stimulated with E. histolytica-
derived SPs from E. histolytica wild-type or mutant strains to
ascertain if SPs directly induce IL-8 production. The results
of this work show that amoebic CPs participate in SP-induced
IL-8 production in HMC-1 cells.
Materials and methods
Reagents
Unless stated otherwise, all other chemicals were purchased
from Sigma-Aldrich (Saint Louis, MO, USA). Mouse monoclo-
nal antibody (Ab) against human protease-activated receptor
2 (PAR2) (SAM 11) and normal mouse IgG2a were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Fluorescent isothiocyanate (FITC)-labeled annexin V, PE-
conjugated anti-human CD63, and PE-conjugated anti-mouse
IgG1j were purchased from BD Pharmingen (San Diego,
CA, USA). Dichlorodihydroﬂuorescein diacetate (H2DCFDA)
was purchased from Molecular Probes (Eugene, OR, USA).
Cultivation of human HMC-1 cells
The HMC-1 human mast cell line was grown in Iscove’s
Modiﬁed Dulbecco’s medium (IMDM) (Invitrogen) containing
10% (v/v) heat-inactivated fetal bovine serum (FBS) and 0.5%
penicillin-streptomycin at 37 C in a humidiﬁed 5% CO2 atmo-
sphere. HMC-1 cell viability, as judged by trypan blue exclu-
sion testing, was 99%.
Culture of bone marrow-derived murine mast cells
(BMMCs) and ethics
BMMCs from BALB/c mice (Orient Bio, Seoul, Korea)
were obtained by culturing mouse femoral bone marrow cells
in RPMI containing 10% (v/v) heat-inactivated fetal bovine
serum, 0.5% penicillin-streptomycin, 50 lM b-mercap-
toethanol, and 20 ng/mL IL-3 (PeproTech, Rocky Hill, NJ,
USA) for 4 weeks. At that time, the cells were > 98% c-kithigh
FceRIhigh, according to ﬂow cytometric analysis using PE anti-
mouse FceRIa (MAR-1) (eBioscience, San Diego, CA, USA)
and FITC anti-mouse c-kit/CD117 (2D8) (eBioscience, San
Diego, CA, USA). The present study was approved by the
Yonsei University Animal Research Ethics Committee
(No. 2013-0297).
Construction of E. histolytica cell lines
overexpressing a GFP-tagged inhibitor of cysteine
protease 1 (ICP1+/+)
To create the ICP1-overexpressing E. histolytica cell line
(ICP1+/+), a full-length E. histolytica ICP1 gene was ampliﬁed
by PCR from cDNA using sense and antisense oligonucleotides
containing appropriate restriction sites (underlined) at the 50-
end: icp1 50-aatcccgggATGTCATTAACTGAAGATAATAAC
AACACAAC-30 (SmaI); and 50-gggctcgagTTACTG GACAT
TAACTTTTAAAGTAAAAG-30 (XhoI). The PCR-ampliﬁed
DNA fragments were digested and ligated into the same restric-
tion sites of the overexpression vector, pKT-MG. This vector
allows for the expression of a gene of interest as a N-terminal
fusion with GFP. The plasmids were introduced into E. histoly-
tica HM-1:IMSS trophozoites by liposome-mediated transfec-
tion as previously described [22], and stable transformants
were cultured in medium containing 8 lg/mL G418 (for
ICP1+/+ and pKT-MG as a vector control).
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Cultivation of E. histolytica trophozoites and
preparation of secretory products
Trophozoites of the E. histolytica virulent HM-1:IMSS
strain, the avirulent E. histolytica Rahman strain, and the
hypo-CP strain ICP1+/+ were grown at 37 C in TYI-S-33 med-
ium as described previously [10]. After cultivation for 48–72 h,
logarithmic growth phase trophozoites were harvested by incu-
bation on ice for 10 min, followed by centrifugation at
1000 rpm at 4 C for 5 min. To collect SPs, trophozoites from
the various strains were incubated in Hanks’ balanced salt solu-
tion (GIBCO Laboratories, Grand Island, NY, USA) for 2 h at
37 C at a ﬁnal concentration of 1 · 107 amoebae per mL. The
viability of Entamoeba trophozoites after incubation in Hank’s
balanced salt solution was 99% as determined by the trypan
blue exclusion assay. Protein concentration was measured by
the BCA protein assay using bovine serum albumin as a
standard.
Measurement of cell viability and cell death
HMC-1 cell viability and cell death were measured by try-
pan blue and annexin V/propidium iodide (PI) double staining,
respectively. HMC-1 cells (5 · 105 cells/sample) stimulated
with SPs were incubated for 2 h at 37 C in a humidiﬁed
CO2 incubator (5% CO2 and 95% air). After incubation, the
reaction was stopped by brief centrifugation, and the cells were
washed with cold PBS twice and stained with FITC-conjugated
annex in V and 1 lg/mL PI. Flow cytometric analysis was per-
formed with a FACScan on at least 10,000 cells from the host
cell fraction.
Measurement of exocytosis in HMC-1 cells or
BMMCs
To elucidate the exocytosis of HMC-1 cells or BMMCs
induced by the SPs, HMC-1 cells or BMMCs (5 · 105 cells/
sample) were incubated with SP (30 or 100 lg/mL) for 2 h,
or platelet-activating factor (PAF) (5 lM) for 1 h or phorbol
12-myristate 13-acetate (PMA) for 2 h. For positive control,
BMMCs were treated with monoclonal anti-DNP IgE
(250 ng/mL) for 4 h, and then the cells were challenged with
DNP-HSA (250 ng/mL) for 1 h to trigger mast cell degranula-
tion. After incubation, the cells were washed twice with wash-
ing buffer (0.1% sodium azide and 1% FBS in PBS) and
stained with PE-conjugated anti-human or anti-mouse CD63.
PE-conjugated anti-mouse IgG1 or anti-rat IgG2a was used as
an isotype control. A ﬂow cytometric analysis was performed
using a FACScan on at least 10,000 cells from each sample.
Quantitative real-time PCR for IL-8 mRNA
expression
HMC-1 cells (1 · 106/sample) were incubated with or
without SPs for 30 min at 37 C in a CO2 incubator. After incu-
bation, total RNA was obtained from HMC-1 cells (1 · 106/
sample) incubated with or without SPs using TRIzol reagent
(Invitrogen Corporation, Carlsbad, CA, USA) and was
reverse-transcribed using a ProSTAR ﬁrst-strand RT-PCR kit
(Stratagene, La Jolla, CA, USA). Obtained cDNA was ampli-
ﬁed using a SYBR Green PCR Master Mix. The primers used
were as follows: human IL-8; 50-TCT GCA GCT CTG TGT
GAA GGT G-30 and 50-AAT TTC TGT GTT GGC GCA
GTG-30, human GAPDH; 50-GAA GGT GAA GGT CGG
AGT C-30 and 50-GAA GAT GGT GAT GGG ATT TC-30.
IL-8 gene expression was analyzed using the Applied Biosys-
tems 7700 Sequence Detection System (Applied Biosystems,
Foster City, CA, USA), according to the manufacturer’s instruc-
tions. The relative amount of mRNA for the genes of interest
was determined by subtracting the threshold cycle (Ct) values
for the gene from the Ct value for the internal control gene
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (DCt).
Each measurement of a sample was performed in triplicate.
The data represent IL-8 mRNA fold induction.
IL-8 ELISA
Formeasurement of IL-8 production, HMC-1 cells (5 · 105/
well) were seeded in 24-well tissue culture plates and then
directly incubated for the indicated times with or without native
or modiﬁed SPs for 12 h at 37 C in a CO2 incubator. After
incubation, culture supernatants were collected from HMC-1
cells. To evaluate the involvement of PAR2 in SP-induced IL-8
production, HMC-1 cells (5 · 105/well) were preincubated with
anti-PAR2 (10 lg/mL) or mouse IgG2a (10 lg/mL) for 30 min.
After preincubation, the cells were incubated for the indicated
times with or without native SPs for 12 h at 37 C in a CO2
incubator. Then, culture supernatants were collected from
HMC-1 cells, and the amount of IL-8 production was measured
with a speciﬁc human IL-8 screening kit (Thermo Scientiﬁc,
Waltham, MA, USA) according to the manufacturer’s
instructions.
Measurement of cysteine protease activity
Native SPs obtained from wild-type amoebae were pre-
treated with or without protease inhibitor (E64 or PMSF) or
heat-modiﬁed SPs (100 C for 10 min), and then CP assays
were performed. In addition, ICP1+/+, vector control, or
Rahman-derived native SPs were also measured for CP activity.
Brieﬂy, E. histolytica trophozoites (4 · 105/well) were incu-
bated in 100 mL Opti-MEM medium (Invitrogen, Carlsbad,
CA, USA) supplemented with 137 mM cysteine and 19 mM
ascorbic acid, pH 6.8 in a 96-well tissue culture plate at
37 C for 1 h. After incubation, the culture supernatant for
secreted CP activity was collected and remaining trophozoites
for intracellular CP activity were obtained by centrifugation.
CP activity was measured according to the cleavage of a
z-Arg-Arg-pNA2 HCl synthetic peptide substrate, which
was monitored spectrophotometrically as described previ-
ously [21, 23].
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Measurement of ROS generation in HMC-1 cells
Intracellular ROS accumulation in HMC-1 cells was mea-
sured by staining cells with the green ﬂuorescence probe
H2DCFDA, which is rapidly oxidized to highly ﬂuorescent
DCF in the presence of intracellular H2O2, and analyzed spec-
troﬂuorometrically (model Axiovert 200). Brieﬂy, HMC-1 cells
(1 · 105 cells/sample) were preloaded with 5 lM H2DCFDA
for 30 min and washed twice with culture medium. The washed
cells were incubated with or without SPs or PAF for up to
30 min at 37 C in a CO2 incubator. The production of
intracellular ROS was determined on a Perkin Elmer LS50B
Figure 1. E. histolytica-derived secretory products (SPs) of pathogenic amoebae do not induce cell death or exocytosis in mast cells.
(A) Percentage of CD63-positive cells in HMC-1 cells incubated with SPs or platelet-activating factor (PAF) (5 lM). (n = 3) (B) Percentage of
CD63-positive cells in bone marrow-derived murine mast cells incubated with SPs, phorbol 12-myristate 13-acetate (PMA) (50nM) or DNP-
HSA (250 ng/mL). (n = 4). (C) Flow cytometry analysis of HMC-1 cell death after stimulation with or without SPs. (n = 4). All reactions
were performed in triplicate measurements of each experiment. All data are presented as the mean ± SEM of at least three independent
experiments. The asterisks indicate the results of comparisons with the controls (**p < 0.01).
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spectroﬂuorometer using excitation and emission wavelengths
of 485 and 530 nm, respectively. All background ﬂuorescence
was subtracted using the appropriate controls.
Statistical analysis
All reactions were performed in triplicate measurements of
each experiment. Results are presented as the mean ± SEM of
3 to 6 independent experiments. One-way analysis of variance
(ANOVA) was performed using the statistical software package
SPSS version 20 for Windows. The post hoc comparisons of
means from different groups were made by the Bonferroni post
hoc test. Values were considered statistically signiﬁcant when
the p-value  0.05.
Results
E. histolytica-derived secretory products do not
induce mast cell degranulation
HMC-1 cells were treated with various concentrations (30
or 100 lg/mL) of SPs for 2 h to examine whether SPs could
induce mast cell activation. CD63 expression is generally used
as a surface marker for degranulation via exocytosis in mast
cells [24]. When HMC-1 cells or BMMCs were treated with
100 lg/mL SP for 2 h, the percentage of CD63-positive cells
was 8.1 ± 1.7 and 4.0 ± 0.6, respectively. However, HMC-1
cells treated with 5 lM PAF or BMMCs treated with DNP-
HSA as a positive control showed a marked increase in
CD63 expression (Figure 1A and 1B). At that time, there was
no difference in cell viability after incubation with SPs for
2 h compared with the results for HMC-1 cells (Figure 1C)
or BMMCs (data not shown) incubated with medium alone.
Stimulation with secretory products increased IL-8
mRNA expression and protein secretion in HMC-1
cells
To examine whether SPs could induce secretion of IL-8 in
HMC-1 cells, real-time PCR and ELISA analyses were per-
formed. The real-time PCR analysis revealed that HMC-1 cells
stimulated with SPs for 30 min resulted in a 3- to 4-fold
increase in IL-8 mRNA as compared with cells treated with
medium alone (Figure 2A). As shown in Figure 2B, SP-
stimulated HMC-1 cells released IL-8 protein in a dose-depen-
dent manner, and HMC-1 cells stimulated with SPs for 12 h
resulted in a 1.7- and 2.4-fold increase in IL-8 protein at 30 and
100 lg/mL SP, respectively, compared with medium-treated
cells. There was no difference in the number of annexin V-
positive HMC-1 cells after incubation with SPs for 12 h com-
pared with the results for cells incubated with medium alone
(data not shown). Interestingly, SPs from the non-pathogenic
Rahman strain showed a 30% reduction compared with SPs
from HM-1:IMSS amoebae (Figure 2C).
Cysteine protease activity is required for IL-8
production in HMC-1 cells induced by secretory
products
To determine if amoebic CPs obtained from wild-type
HM-1:IMSS SPs are responsible for SP-triggered IL-8
Figure 2. E. histolytica-derived secretory products (SPs) from the pathogenic wild-type HM-1:IMSS strain induce IL-8 gene expression and
protein secretion in HMC-1 cells. (A) Increased IL-8 mRNA expression in HMC-1 cells induced by SPs. (n = 3) (B) IL-8 production in SPs-
stimulated HMC-1 cells. (n = 6) (C) Comparison of IL-8 production in HMC-1 cells stimulated with SPs obtained from wild-type or non-
pathogenic Rahman strains. (n = 4). All reactions were performed in triplicate measurements of each experiment. Data are presented as the
mean ± SEM of at least three independent experiments. The asterisks indicate the results of comparisons with the controls (*p < 0.05,
**p < 0.01).
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production in mast cells, modiﬁed SPs were incubated with
HMC-1 cells. As shown in Figure 3A, the IL-8 production
induced by SPs was abolished by pretreatment of the SPs with
heat, suggesting that Entamoeba-secreted heat-labile protein
components may participate in IL-8 production in HMC-1 cells.
SP-induced IL-8 production in HMC-1 cells was signiﬁcantly
reduced by pretreatment of the SPs with the cysteine protease
inhibitor E64c. Next, we compared the CP activity of native
or modiﬁed SPs by treatment with speciﬁc protease inhibitors.
As shown in Figure 3B, cysteine protease inhibitor E64c-treated
SPs and heat-treated SPs from the wild-type signiﬁcantly
reduced CP activity as compared with untreated SPs. In con-
trast, serine protease inhibitor PMSF-treated SPs had no inhib-
itory effect on CP activity. To demonstrate that amoebic CP is
responsible for SP-triggered IL-8 production in mast cells, we
observed the IL-8 production in HMC-1 cells by SPs from
the ICP1+/+ strain. SPs derived from the ICP1+/+ strain resulted
in a decrease in IL-8 production compared with its transfectant
control (Figure 4A). In addition, a marked reduction of CP
activity was observed in SPs obtained from the ICP1+/+ strain
compared with its vector control amoebae (Figure 4B).
Secretory products-induced IL-8 production
in HMC-1 cells occurs through a PAR2- and
ROS-independent mechanism
Next, we investigated whether PAR2, which is a known
G-coupled receptor, is involved in IL-8 production induced
by SPs. HMC-1 cells were preincubated with monoclonal Ab
(10 lg/mL) to PAR2 or the isotype control IgG2a for 30 min
at room temperature and subsequently incubated for 12 h with
or without SPs. As shown in Figure 5A, Ab to PAR2 did not
Figure 3. Amoebic cysteine protease activity is required for IL-8
production in HMC-1 cells induced by E. histolytica-derived
secretory products (SPs). (A) IL-8 production in HMC-1 cells
stimulated with SPs from native or modiﬁed wild-type SPs either
heat-treated (100 C, 10 min) or treated with 25 lM protease
inhibitor (E64c). (n = 4) (B) CP activity from native or modiﬁed
wild-type SPs with heat- (100 C, 10 min) or 25 lM protease
inhibitor (E64c or PMSF) treatment were measured using z-Arg-
Arg-pNAÆ2 HCl as a substrate. The level of activity is shown as a
percentage relative to the control. (n = 3). All reactions were
performed in triplicate measurements of each experiment. Data are
presented as the mean ± SEM of at least three independent
experiments. The asterisks indicate the results of comparisons with
the controls (*p < 0.05. **p < 0.01). Figure 4. E. histolytica-derived secretory products (SPs) from the
inhibitor of cysteine protease 1 (ICP1+/+) strain show a reduction in
IL-8 protein secretion and cysteine protease activity in HMC-1 cells.
(A) IL-8 production in HMC-1 cells stimulated with SPs from the
ICP1+/+ or vector control strain. (n = 4) (B) The CP activity of SPs
from the ICP1+/+ or vector control strain was measured using z-Arg-
Arg-pNAÆ2 HCl as a substrate. (n = 3). All reactions were performed
in triplicate measurements of each experiment. Data are presented as
the mean ± SEM of at least three independent experiments. The
asterisks indicate the results of comparisons with the controls
(*p < 0.05).
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inhibit SP-induced IL-8 production in HMC-1 cells. Next, we
investigated whether ROS were involved in the SP-induced
IL-8 production in HMC-1 cells. As shown in Figure 5B, intra-
cellular ROS were not detected in SP-stimulated HMC-1 cells
within 30 min. In contrast, intracellular ROS levels were
strongly increased in HMC-1 cells stimulated with PAF as a
positive control.
Discussion
In this study, our results show that amoebic CP participates
in IL-8 production through a PAR2-independent pathway in
HMC-1 cells. E. histolytica-derived SPs containing serine or
amoebic CPs have been shown to constantly secrete CPs into
the extracellular environment [1, 18]. The SPs of the Rahman
and ICP1+/+ strains resulted in a signiﬁcant decrease in IL-8
production in HMC-1 cells compared with the SPs of wild-type
Entamoeba, suggesting that a reduction in CP activity may
result in a signiﬁcant reduction of SP-induced IL-8 production
in HMC-1 cells. Our data indicate that amoebic CP might be
involved in IL-8 production in HMC-1 cells.
Recent work has shown that E. histolytica SPs can mark-
edly increase IL-8 mRNA expression and protein production
in colonic epithelial cells [9]. In addition, recent studies have
provided evidence that chemokines such as IL-8 are crucial
mediators in inﬂammation and in tissue injury in intestinal
inﬂammation. IL-8 is a small, 8- to 11-kDa secreted protein that
may participate in immune and inﬂammatory responses through
chemoattraction and activation of neutrophils or leukocytes [1].
E. histolytica invades the intestinal mucosa and causes amoebic
colitis and severe ulceration. Analysis of the inﬂammatory
response during intestinal amoebiasis in human and animal
models of the disease has revealed an important regulatory role
for chemokines and cytokines. Recruitment and activation of
inﬂammatory cells are modulated by secreted amoebic factors.
SPs contain many components including cysteine protease
(CP), serine protease, other proteases, phosphatases and prosta-
glandin E2 (PGE2).
In our preliminary experiment, we got IL-8 results of
HMC-1 cells stimulated with ﬁve various concentrations (0,
10, 30, 100, and 200 lg/mL) of SP. However, no effect of
10 lg/mL of SP on IL-8 production was observed. In addition,
the highest concentration of SP (200 lg/mL) showed a cytotoxic
effect on HMC-1 cells (about 10% of cells were dead for 12 h),
although the amount of IL-8 release in SP (200 lg/mL)-stimu-
lated cells showed a similar level compared with the result of
stimulation with 100 lg/mL (data not shown). As a result, we
chose 30 and 100 lg/mL concentrations for all experiments.
In the present study, the amount of IL-8 production in
HMC-1 cells induced by heat-treated SPs (100 C for 10 min)
abrogated IL-8 production, suggesting that heat-labile proteins
participate in IL-8 production in HMC-1 cells. Interestingly, this
result is consistent with the fact that the RGD motif in pro-
mature CP5 (PCP) binds to integrin of colon cells and induces
NF-kB-mediated IL-8 production in Caco-2 cells [15]. In addi-
tion, SPs from the Rahman strain resulted in a signiﬁcant
decrease in IL-8 production in HMC-1 cells, whereas IL-8 pro-
duction by the ICP1+/+ strain, which is deﬁcient in CP, was
slightly diminished. This result is in agreement with the report
that the Rahman strain decreased CP expression. According to a
previous report [9], PGE2 participation in SP-induced IL-8 pro-
duction was demonstrated in colon cells, where boiled amoebic
secretory product (100 C for 30 min) abolished SP-stimulated
IL-8 production. However, involvement of the lipid mediator
PGE2 in SP-stimulated IL-8 production in HMC-1 cells was
not investigated in this study.
There is no information on how SPs can induce mast cell
activation such as IL-8 release. G-coupled receptors or Toll-like
receptors (TLR) residing on the mast cell surface may act as the
biological sensor for various infectious agents during the pro-
cess of mast cell activation. For example, certain proteases,
including serine protease and trypsin, are signaling molecules
Figure 5. E. histolytica-derived secretory product (SP)-induced IL-8
production in HMC-1 cells occurs through a protease-activated
receptor 2 (PAR2) or ROS-independent mechanism. (A) The effect
of anti-PAR2 on SP-stimulated IL-8 production. (n = 4) (B) The
effect of SPs on induction of ROS generation at 30 min in HMC-1
cells. (n = 3). All reactions were performed in triplicate measure-
ments of each experiment. Data are presented as the mean ± SEM of
at least three independent experiments. The asterisks indicate the
result of comparisons with the control (*p < 0.05).
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that regulate cells by cleaving and triggering PARs [27].
Accordingly, involvement of the PAR2 receptor that is activated
by serine protease and occasionally by cysteine protease was
tested. In particular, PAR2 is closely related to inﬂamma-
tion [8]. Although SPs contain many kinds of proteases includ-
ing serine, cysteine and aspartic proteases, SP-induced IL-8
production in mast cells did not occur via the PAR2 receptor.
Also, it is well known that TLRs act as biological sensors of
various infectious agents (i.e., viruses, bacteria, or fungi) or
their products (such as lipopolysaccharide, lipoteichoic acid,
and peptidoglycan) and are expressed by various innate
immune cells (i.e., macrophages, neutrophils, or dendritic cells)
[7, 17]. In addition to recognizing external dangers, TLRs also
regulate the immune response by recognizing endogenously
produced danger signals including necrotic cells, heat shock
proteins, or ECM breakdown products [5]. As such, TLRs
may participate in SP-induced mast cell activation; however,
more experimentation is needed to investigate TLR involve-
ment in response to SPs.
In conclusion, we have demonstrated that CPs present in
SPs contribute to IL-8 production in human mast cells. Addi-
tionally, non-pathogenic Rahman and the CP-deﬁcient
ICP1+/+ strains showed a decrease in IL-8 production, suggest-
ing the involvement of amoebic CP in the host cell response
induced by E. histolytica infection, helping us to understand
the mechanism of pathogenesis in E. histolytica.
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